Used in pharmaceutical research as a potent and selective antagonist of the angiotensin II receptor subtype AT1, this compound plays a key role in studying cardiovascular diseases. It helps in evaluating pathways related to hypertension and vascular remodeling. Due to its high affinity for the AT1 receptor, it is employed in receptor binding assays and functional studies to block angiotensin II-induced effects in cellular and animal models. Its sulfonamide and oxadiazole moieties contribute to metabolic stability and receptor selectivity, making it valuable in the development of new antihypertensive agents.